Google's AI-powered tools accelerate drug discovery and boost company value.

Google Cloud has launched two AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine. The Target and Lead Identification Suite helps companies predict and understand the structure of proteins, while the Multiomics Suite helps researchers ingest, store, analyze and share mass amounts of genomic data. The suites will save companies a "statistically significant" amount of time and money throughout the drug development process, addressing a long-standing issue in the biopharma industry.